Cargando…

Nonalcoholic fatty liver disease: new treatments

PURPOSE OF REVIEW: Nonalcoholic fatty liver disease is the most common cause of liver dysfunction in the western world because of its close association with obesity, insulin resistance and dyslipidaemia. Nonalcoholic steatohepatitis (NASH) is a particular health concern due to the increased morbidit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hardy, Timothy, Anstee, Quentin M., Day, Christopher P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	LIVER: Edited by Don C. Rockey
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482455/ https://www.ncbi.nlm.nih.gov/pubmed/25774446 http://dx.doi.org/10.1097/MOG.0000000000000175

Ejemplares similares

Carnitine derivatives beyond fatigue: an update
por: Malaguarnera, Michele, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
por: Dyson, Jessica K, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls
por: Hallsworth, Kate, et al.
Publicado: (2015)

Non-alcoholic fatty liver disease: a practical approach to treatment
por: Dyson, J K, et al.
Publicado: (2014)

Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease
por: Neilson, Laura Jane, et al.
Publicado: (2021)

Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
por: Mowry, Christopher J., et al.
Publicado: (2021)

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
por: McPherson, Stuart, et al.
Publicado: (2017)

Effect of Nonalcoholic Fatty Liver Disease and Metabolic Risk Factors on Waitlist Outcomes in Patients With Hepatocellular Carcinoma
por: Weinfurtner, Kelley, et al.
Publicado: (2020)

Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent
por: De Silva, Sampath, et al.
Publicado: (2018)

Prospective Study to Analyze the Concordance Between a Standardized Visual Method With Pathology to stratify Nonalcoholic Fatty Liver Disease in Cadaveric Liver Grafts Evaluated for Transplantation
por: Sampaio-Neto, José, et al.
Publicado: (2023)

Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease
por: Hall, Zoe, et al.
Publicado: (2017)

IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice
por: Harley, Isaac TW, et al.
Publicado: (2014)

Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic Steatohepatitis
por: Satapathy, Sanjaya K., et al.
Publicado: (2020)

The endothelial function biomarker soluble E‐selectin is associated with nonalcoholic fatty liver disease
por: Simons, Nynke, et al.
Publicado: (2020)

Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients
por: Anty, Rodolphe, et al.
Publicado: (2014)

Resting and Exercise Energy Metabolism After Liver Transplantation for Nonalcoholic Steatohepatitis
por: Levitsky, Josh, et al.
Publicado: (2017)

Immune Features of Disparate Liver Transplant Outcomes in Female Hispanics With Nonalcoholic Steatohepatitis
por: Sosa, Rebecca A., et al.
Publicado: (2023)

Circulating trimethylamine‐N‐oxide is associated with all‐cause mortality in subjects with nonalcoholic fatty liver disease
por: Flores‐Guerrero, Jose L., et al.
Publicado: (2021)

Network and satellite arrangements in liver disease
por: O'Grady, John G
Publicado: (2013)

Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosis
por: Allende, Daniela S, et al.
Publicado: (2021)

Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis(1)(2)(3)(4)
por: Chung, Mei, et al.
Publicado: (2014)

TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease
por: Yilmaz, Yusuf, et al.
Publicado: (2023)

Magnetic Resonance Elastography Predicts Advanced Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Study
por: Loomba, Rohit, et al.
Publicado: (2014)

Resmetirom: An Orally Administered, Smallmolecule, Liver-directed, β-selective THR Agonist for the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
por: Karim, Gres, et al.
Publicado: (2023)

Reluctance to Accept Alcohol Treatment by Alcoholic Liver Disease Transplant Patients: A Qualitative Study
por: Heyes, Cathy M., et al.
Publicado: (2016)

Development and implementation of a commissioned pathway for the identification and stratification of liver disease in the community
por: Chalmers, Jane, et al.
Publicado: (2019)

Liver dysfunction in COVID-19: a useful prognostic marker of severe disease?
por: Lok, James, et al.
Publicado: (2020)

Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood
por: Decaris, Martin L., et al.
Publicado: (2016)

Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men
por: Yang, Hae Jin, et al.
Publicado: (2016)

Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease
por: Tokushige, Katsutoshi, et al.
Publicado: (2013)

Medical liver biopsy: background, indications, procedure and histopathology
por: Boyd, Alexander, et al.
Publicado: (2019)

Donor acquired visceral leishmaniasis following liver transplantation
por: Dhaliwal, Amritpal, et al.
Publicado: (2021)

Provision and standards of care for treatment and follow-up of patients with Autoimmune Hepatitis (AIH)
por: Gordon, Victoria Mary, et al.
Publicado: (2021)

Patient understanding of liver cirrhosis and improvement using multimedia education
por: Goldsworthy, Matthew A, et al.
Publicado: (2017)

Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan
por: Yoneda, Masato, et al.
Publicado: (2021)

Global strategy for the diagnosis and management of acute kidney injury in patients with liver cirrhosis
por: Sanchez, Lukas Otero, et al.
Publicado: (2021)

Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans
por: Liu, Wanqing, et al.
Publicado: (2016)

Adult liver transplantation: UK clinical guideline - part 2: surgery and post-operation
por: Millson, Charles, et al.
Publicado: (2020)

Adult liver transplantation: A UK clinical guideline - part 1: pre-operation
por: Millson, Charles, et al.
Publicado: (2020)

Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)
por: Brennan, Paul N, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_neo0l82njs5vfl9pmrq5i6qhsc